Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jan 10;16(1):412-26.
doi: 10.3390/molecules16010412.

Phage display for the generation of antibodies for proteome research, diagnostics and therapy

Affiliations
Review

Phage display for the generation of antibodies for proteome research, diagnostics and therapy

Thomas Schirrmann et al. Molecules. .

Abstract

Twenty years after its development, antibody phage display using filamentous bacteriophage represents the most successful in vitro antibody selection technology. Initially, its development was encouraged by the unique possibility of directly generating recombinant human antibodies for therapy. Today, antibody phage display has been developed as a robust technology offering great potential for automation. Generation of monospecific binders provides a valuable tool for proteome research, leading to highly enhanced throughput and reduced costs. This review presents the phage display technology, application areas of antibodies in research, diagnostics and therapy and the use of antibody phage display for these applications.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic overview of the selection of antibodies (“panning“) by phage display.

Similar articles

Cited by

References

    1. von Behring E., Kitasato S. Über das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Thieren. Deut. Med. Wochenzeitschr. 1890;16:1113–1114. doi: 10.1055/s-0029-1207589. - DOI - PubMed
    1. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256:495–497. - PubMed
    1. Winter G., Milstein C. Man-made antibodies. Nature. 1991;349:293–299. doi: 10.1038/349293a0. - DOI - PubMed
    1. Courtenay-Luck N.S., Epenetos A.A., Moore R., Larche M., Pectasides D., Dhokia B., Ritter M.A. Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms. Cancer Res. 1986;46:6489–6493. - PubMed
    1. Tjandra J.J., Ramadi L., McKenzie I.F. Development of human anti-murine antibody (HAMA) response in patients. Immunol. Cell Biol. 1990;68:367–376. doi: 10.1038/icb.1990.50. - DOI - PubMed

Publication types

LinkOut - more resources